Hologic Inc

NASDAQ: HOLX
$77.47
-$1.53 (-1.9%)
Closing Price on December 3, 2024

HOLX Stock Chart and Intraday Price

HOLX Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Address 250 CAMPUS DRIVE, MARLBOROUGH, MA, US
Fiscal Year End September
Latest Quarter 12/31/2023
Market Cap 17,288.01M USD
Shares Outstanding 234,732,000
Hologic Inc. is a leading provider in women's health, offering a wide range of diagnostics, medical imaging systems, and surgical products aimed at early detection and treatment. Its portfolio includes molecular diagnostic assays for infectious diseases, advanced solutions for breast cancer care, including 3D mammography and biopsy systems, as well as surgical products for gynecological procedures like fibroid and polyp removal. Additionally, Hologic offers skeletal health solutions with its dual energy X-ray system. Founded in 1985, the company is dedicated to improving women's health through innovation and is headquartered in Marlborough, Massachusetts.

HOLX Articles

Monday's top analyst upgrades and downgrades included Amazon.com, AT&T, Broadcom, Corning, DraftKings, Eli Lilly, Fortinet, General Mills, Leslie’s, Microsoft, Nvidia, Plug Power, Progressive,...
Thurs day's top analyst upgrades and downgrades included Ally Financial, APA, Caesars Entertainment, Chevron, Danaher, Datadog, EOG Resources, EQT, Harley-Davidson, Las Vegas Sands, Netflix, Pioneer...
Monday’s additional top analyst upgrades and downgrades included Blend Labs, Crocs, Gold Fields, Hologic, Leslie’s, Ollie’s Bargain Outlet, Quest Diagnostics and Welltower.
Tuesday's top analyst upgrades and downgrades included American Express, DTE Energy, DuPont, Hologic, Ingersoll Rand, Nvidia and 3M.
These are five top picks for 2021 from Jefferies for investors looking to add health care stocks to their portfolios. Many across Wall Street feel that the sector will continue to remain strong in...
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Chewy, DraftKings, Exxon Mobil, McAfee, Nvidia, Square, Tilray and Walt Disney.
Thursday's top analyst upgrades and downgrades included Biogen, Honeywell, Microsoft, Ping Identity, Qualcomm, Verizon Communications and Wendy's.
Here are eight stocks surging on earnings and seeing the bulk of the analysts who follow the companies issuing much higher price targets ahead.
Wednesday's top analyst upgrades and downgrades included Apache, Apple, CME, Devon Energy, Diamondback Energy, Gilead Sciences, Hexo, MarketAxess, Microchip Technology and Zoom Video Communications.
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk and Whirlpool.
The top analyst upgrades, downgrades and initiations for Wednesday included Acorda Therapeutics, Activision Blizzard, Bloom Energy, Care.com, CBS, Deere and Ferrari.
Wednesday was a flat day for the broad U.S. markets. Each of the major exchanges started out the day on a negative note, but as the session went on markets moved higher. Crude oil made a solid gain...
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix and Sirius XM.
The top analyst upgrades, downgrades and other research calls from Thursday include Andeavor, Discovery, Estee Lauder, Esperion Therapeutics, Hologic, Nvidia and Yum Brands.
Canaccord Genuity's diagnostics analyst Mark Massaro has released his own top picks for 2018. These top five picks in the space have a combined market cap of over $70 billion.